TY - JOUR
T1 - The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix
AU - Takahashi, Yutaka
AU - Koizumi, Masahiko
AU - Sumida, Iori
AU - Isohashi, Fumiaki
AU - Ogata, Toshiyuki
AU - Akino, Yuichi
AU - Yoshioka, Yasuo
AU - Maruoka, Shintaro
AU - Inoue, Shinichi
AU - Konishi, Koji
AU - Ogawa, Kazuhiko
PY - 2012/11
Y1 - 2012/11
N2 - To develop an easy independent patient-specific quality assurance (QA) method using a benchmark plan for high-dose-rate intracavitary brachytherapy for cervix cancer, we conducted benchmark treatment planning with various sizes and combinations of tandem-ovoid and tandem-cylinder applications with 'ideal' geometry outside the patient. Two-dimensional-based treatment planning was conducted based on the Manchester method. We predicted the total dwell time of individual treatment plans from the air kerma strength, total dwell time and prescription dose of the benchmark plan. In addition, we recorded the height (dh), width (dw) and thickness (dt) covered with 100 isodose line. These parameters were compared with 169 and 29 clinical cases for tandem-ovoid or tandem-cylinder cases, respectively. With regard to tandem-ovoid cases, differences in total dwell time, dh, dt and dw between benchmark and individual plans were on average -0.2 ± 3.8, -1.0 mm ± 2.6 mm, 0.8 mm ± 1.3 mm and -0.1 mm ± 1.5 mm, respectively. With regard to tandem-cylinder cases, differences in total dwell time, dhfront (the distance from tandem tip to tandem ring), dt and dw between benchmark and individual plans were on average -1.5 ± 3.1, -1.5 mm ± 4.9 mm, 0.1 mm ± 1.0 mm and 0.2 mm ± 0.8 mm, respectively. Of two cases, more than 13 differences in total dwell time were observed between benchmark plans and the clinical cases, which turned out to be due to the use of the wrong source position setting. These results suggest that our method is easy and useful for independent verification of patient-specific treatment planning QA.
AB - To develop an easy independent patient-specific quality assurance (QA) method using a benchmark plan for high-dose-rate intracavitary brachytherapy for cervix cancer, we conducted benchmark treatment planning with various sizes and combinations of tandem-ovoid and tandem-cylinder applications with 'ideal' geometry outside the patient. Two-dimensional-based treatment planning was conducted based on the Manchester method. We predicted the total dwell time of individual treatment plans from the air kerma strength, total dwell time and prescription dose of the benchmark plan. In addition, we recorded the height (dh), width (dw) and thickness (dt) covered with 100 isodose line. These parameters were compared with 169 and 29 clinical cases for tandem-ovoid or tandem-cylinder cases, respectively. With regard to tandem-ovoid cases, differences in total dwell time, dh, dt and dw between benchmark and individual plans were on average -0.2 ± 3.8, -1.0 mm ± 2.6 mm, 0.8 mm ± 1.3 mm and -0.1 mm ± 1.5 mm, respectively. With regard to tandem-cylinder cases, differences in total dwell time, dhfront (the distance from tandem tip to tandem ring), dt and dw between benchmark and individual plans were on average -1.5 ± 3.1, -1.5 mm ± 4.9 mm, 0.1 mm ± 1.0 mm and 0.2 mm ± 0.8 mm, respectively. Of two cases, more than 13 differences in total dwell time were observed between benchmark plans and the clinical cases, which turned out to be due to the use of the wrong source position setting. These results suggest that our method is easy and useful for independent verification of patient-specific treatment planning QA.
KW - Manchester method
KW - benchmark plan
KW - high-dose-rate intracavitary brachytherapy
KW - independent verification
KW - treatment planning
KW - uterine cervix
UR - http://www.scopus.com/inward/record.url?scp=84870008034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870008034&partnerID=8YFLogxK
U2 - 10.1093/jrr/rrs035
DO - 10.1093/jrr/rrs035
M3 - Article
C2 - 22843371
AN - SCOPUS:84870008034
SN - 0449-3060
VL - 53
SP - 936
EP - 944
JO - Journal of radiation research
JF - Journal of radiation research
IS - 6
ER -